Assessment criteria for vitamin D deficiency/insufficiency in Japan — proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society [Opinion]

  • Okazaki Ryo
    Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan
  • Ozono Keiichi
    Department of Pediatrics, Osaka University Graduate School of Medicine, Suita 565-0871, Japan
  • Fukumoto Seiji
    Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima 770-8503, Japan
  • Inoue Daisuke
    Third Department of Medicine, Teikyo University Chiba Medical Center, Ichihara 299-0111, Japan
  • Yamauchi Mika
    Internal Medicine 1, Shimane University Faculty of Medicine, Izumo 693-8501, Japan
  • Minagawa Masanori
    Department of Endocrinology, Chiba Children’s Hospital, Chiba 266-0007, Japan
  • Michigami Toshimi
    Department of Bone and Mineral Research, Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi 594-1101, Japan
  • Takeuchi Yasuhiro
    Division of Endocrinology, Toranomon Hospital Endocrine Center, Tokyo 105-8470, Japan
  • Matsumoto Toshio
    Fujii Memorial Institute of Medical Sciences, Tokushima University, Tokushima 770-8503, Japan
  • Sugimoto Toshitsugu
    Internal Medicine 1, Shimane University Faculty of Medicine, Izumo 693-8501, Japan

書誌事項

タイトル別名
  • Assessment criteria for vitamin D deficiency/insufficiency in Japan — proposal by an expert panel supported by Research Program of Intractable Diseases, Ministry of Health, Labour and Welfare, Japan, The Japanese Society for Bone and Mineral Research and The Japan Endocrine Society [Opinion]

この論文をさがす

抄録

Vitamin D is indispensable for the maintenance of bone and mineral health. Inadequate vitamin D action increases the risk for various musculoskeletal/mineral events including fracture, fall, secondary hyperparathyroidism, diminished response to antiresorptives, rickets/osteomalacia, and hypocalcemia. Its most common cause in recent years is vitamin D deficiency/insufficiency, clinically defined by low serum 25-hydroxyvitamin D [25(OH)D] level. Guidelines for vitamin D insufficiency/deficiency defined by serum 25(OH)D concentrations have been published all over the world. In Japan, however, the information on the associations between serum 25(OH)D and bone and mineral disorders has not been widely shared among healthcare providers, partly because its measurement had not been reimbursed with national medical insurance policy until August 2016. We have set out to collect and analyze Japanese data on the relationship between serum 25(OH)D concentration and bone and mineral events. Integrating these domestic data and published guidelines worldwide, here we present the following assessment criteria for vitamin D sufficiency/insufficiency/deficiency using serum 25(OH)D level in Japan. 1) Serum 25(OH)D level equal to or above 30 ng/mL is considered to be vitamin D sufficient. 2) Serum 25(OH)D level less than 30 ng/mL but not less than 20 ng/mL is considered to be vitamin D insufficient. 3) Serum 25(OH)D level less than 20 ng/mL is considered to be vitamin D deficient. We believe that these criteria will be clinically helpful in the assessment of serum 25(OH)D concentrations and further expect that they will form a basis for the future development of guidelines for the management of vitamin D deficiency/insufficiency.

収録刊行物

  • Endocrine Journal

    Endocrine Journal 64 (1), 1-6, 2017

    一般社団法人 日本内分泌学会

被引用文献 (13)*注記

もっと見る

参考文献 (27)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報

問題の指摘

ページトップへ